This one-day conference focuses on up-and-coming biotech companies in the Boston area. The conference announcement promises “Senior executives from companies include AVEO Pharmaceuticals, Constellation Pharmaceuticals, Dicerna Pharmaceuticals, Genocea Biosciences, Hydra Biosciences, Magen BioSciences, Pervasis Therapeutics, Sirtris Pharmaceuticals, TheraGenetics, Trubion Pharmaceuticals and Vertex Pharmaceuticals are among the scheduled speakers for the conference.”
The organizers of the conference are Sirtis CEO Christoph Westphal and Michelle Dipp, Senior Director of Corporate Development. Xconomy reported extensively about GlaxoSmithKline’s acquisition of Sirtis and talked with Dipp about its impact on their local presence.
Event web site: www.bostonbiotechconference.com/rd-conference.html
Author: Richard Freierman
Richard has 30 years experience keeping the wheels on the bus, starting at Computer Design & Applications, where he created and managed an engineering support group charged with software technical publications, beta testing, and software release. His subsequent management and operations experience has included the Image and Meaning Conference (MIT 2001), retail management for Video Signals, a 7 store regional chain, and campaign management for four successful municipal elections in Cambridge, MA. Around the dawn of the World Wide Web, Richard was Web guru and creative partner for the Family Surfboard, a website for kids’ online activities. He also co-authored Save the Earth at Work (Bob Adams Inc., 1991) and Corporate Realities and Environmental Truths (Wiley, 1993). While Richard doesn’t get to apply his SUNY Forestry Degree very often in Cambridge, it does help him see the forest for the trees.
View all posts by Richard Freierman
